Die Arbeitsgemeinschaft Dermatologische Forschung schreibt verschiedene Preise zur Auszeichnung von Wissenschaftlern/Wissenschaftlerinnen auf dem Gebiet der dermatologischen Forschung aus. Neben dem Paul-Langerhans-Preis für etablierte Forscher und dem Egon-Macher-Preis für Nachwuchsforscher werden auf den ADF-Jahrestagungen herausragende Arbeiten auf dem Gebiet der Allergologie (ADF/ECARF-Award für Allergologie) und der Onkologie (Dermato-Onkologie-Nachwuchs-Preise) geehrt.

Zusätzlich werden die besten Poster mit einem Posterpreis prämiert.

Für die kompletten Ausschreibungstexte sowie die detaillierten Vergaberichtlinien klicken Sie bitte den hervorgehobenen Link an.

Bitte beachten Sie:
Für die Posterpreise, den ADF/ECARF-Award for European Allergy Research sowie die Dermato-Onkologie-Nachwuchspreise ist eine separate Bewerbung nicht notwendig. Für diese Preise werden alle fristgerecht als Abstract eingereichten Arbeiten bewertet.
Einsendungen für den Paul-Langerhans-Preis und den Egon-Macher-Preis sollen in allen Fällen ausschließlich in elektronischer Form als eine PDF-Datei an die ADF-Geschäftsstelle erfolgen.
Der Einsendeschluss ist der 1. November!



Die Arbeitsgemeinschaft Dermatologische Forschung verleiht auf ihren Jahrestagungen mehrere Posterpreise. Diese sind mit EUR 1.000,-- pro Preisträger dotiert. Die Auswahl der Preisträger und die Vergabe der Preise erfolgen durch eine Jury auf der jeweiligen Jahrestagung.

Stifter der Posterpreise sind:

6 Posterpreise gestiftet von Almirall Hermal GmbH



2 Posterpreise gestiftet von Lilly Deutschland GmbH


1 Posterpreis gestiftet von Bio Legend GmbH


1 Posterpreis gestiftet von Dr. August Wolff GmbH & Co. KG - Arzneimittel


1 Posterpreis gestiftet von head & shoulders


1 Posterpreis gestiftet von Sanofi-Aventis Deutschland GmbH

Bisherige Preisträger des ADF-Posterpreise

Christian Adam, Würzburg
Potent NLRP3 inflammasome activation by the allergy-inducing HIV reverse-transcriptase inhibitor abacavir

Benedikt Herold/Juliane de Vries, Ulm
Osteopontin as a potential regulator of dermal ABCB5+ MSC maintenance

A. Kwaczala-Tessmann, Göttingen
Cytoskeletal reorganization during NET formation

E. Rodríguez, Kiel
Global RNA expression profiling in skin provides insights into disease mechanisms of atopic eczema and psoriasis

David Rafei-Shamsabadi, Freiburg
Type 2 innate lymphoid cells act as regulators of type I driven TNCB contact hypersensitivity

Franziska Krebs, Mainz
Investigating immunosuppressive regulatory T cells (Treg) and myeloid-derived suppressor cells (MDSC) in checkpoint inhibitor therapy of malignant melanoma

Vida Farsam, Ulm
Senescent fibroblasts enhance cutaneous squamous cell carcinoma progression through secretion of Chemerin and activation of MAPK pathway

Christine Hosp, Würzburg
Successful immunotherapy in a new mouse model of wasp venom allergy

Jana Knüver, Köln
Myeloid cell-restricted Insulin/IGF-1 signaling controls cutaneous inflammation

Corinna Kosnopfel, Tübingen
In and outside the melanoma cell: The Y-box binding protein 1 as a novel tumour marker and therapeutic target in vemurafenib resistance

Maria Schmidgen, Mainz
Role of protease-activated receptor 2- and tissue factor-mediated signaling in contact hypersensitivity

Emmi Wachsmuth
Map kinase p38alpha stress signaling repairs skin barrier defects caused by loss of insulin/IGF-1 signaling

Andrea Braun, Göttingen
Integrin αE(CD103) - a modulator of regulatory T cell function in allergic contact hypersensitivity

Timo Buhl; Göttingen
Epidermal PAR2 overexpression causes atopic dermatitis-like skin disease: Neuro-epidermal communication

Claudia Günther, Dresden
Defective removal of ribonucleotides from DNA promotes systemic lupus erythematosus

Elena Makino, Tübingen
The role of beta-catenin in the therapy resistance of malignant melanoma to BRAF inhibitors

Kathrin Tarnanidis, Heidelberg
RAGE signaling drives the initiation and maintenance of the psoriatic inflammation

Susanne Vorhagen, Köln
Unraveling the role of aPKCλ in the regulation of oriented cell division and stem cell homeostasis in the mammalian epidermis

S. A. Graf, München
The role of SOX10 in melanoma cell invasion

S. Kaesler, Tübingen
TLR2-ligands promote chronic atopic dermatitis inflammation based on IL-4-mediated suppression of IL-10

B. Kraft, Tübingen
Immune conditioning of the epithelial surface by skin microbiota enhances innate immune response towards pathogens

M. Rogava, Bonn
Sensing of UVB-induced DNA damage in the skin by the innate immune system involves the TLR4- and MyD88-dependent signaling pathway.

M. Rübsam, Köln
Classical cadherins control epidermal barrier function: regulation through actomyosin?

D. Terhorst, Berlin
Laser-assisted intradermal delivery of Xcl1-specific fusion vaccines induces potent anti-tumor response

K. Satoh, Mainz
Kinome profiling of human regulatory T cells reveals novel target structures to modify their functional activity

Y. Qi, Ulm
Phenotypic Switching from M1 to M2 Macrophages by Mesenchymal Stem Cells Improves Wound Healing in an Iron-Overload Mouse Model

A. Hossini, Dessau
Induced pluripotent stem cell-derived neurons from a sporadic Alzheimer's disease donor as a model for investigating disease mechanisms

S. Käsler, Tübingen
Mast cells establish effective anti-tumor immune defense

Y. Skabytska, Tübingen
Post-septic immune-suppression following Gram positive sepsis is mediated by TLR dependent induction of myeloid derived suppressor cells.

T. Bald, Bonn
TLR4-dependent inflammation in the tumor microenvironment expands myeloid-derived suppressor cells that promote metastatic progression of melanoma in the Hgf-Cdk4 mouse model

Stephanie Traub, Köln
Agonistic VEGF-variants engineered to simultaneously bind to and stimulate VEGFR-2 and alphaVbeta3 integrin

L. Froesewitte, Kiel
Is Loricrin a trojan horse antimicrobial peptide mimicking a bacterial microcin B17 precursor?

D. Beck, Tübingen
The BRAFV600E kinase inhibitor vemurafenib induces apoptosis through a process involving induction of endoplasmic reticulum stress in melanoma cells

Maria Gaiser, Bethesda/Heidelberg
Langerhans cell-selective deletion of EpCAM (CD326) attenuates Langerhans cell motility and migration in vivo and enhances contact hypersensitivity reactions

Anja Rabenhorst, Köln
Mast cells play a protumorigenic role in primary cutaneous lymphoma

E. Doyle, Berlin
Tryptase therapy counteracts lethal effects of snake venom: a new treatment for snakebite

A. Schlecht, Ulm
Beta2 integrin-dependent release of oxygen radicals from macrophages is required for TGF-beta1 activation in cutaneous wound repair

Astrid Schmieder, Mannheim
Pro- and anti-inflammatory signalling cascades synergize to induce an M2-like tumor macrophage-associated activation pathway involving the novel CD20 homolog Ms4a8a

Stefanie Hoyer, Erlangen
Providing T-cell help to dendritic cells to induce better anti-tumor immune responses

Christian Hafner, Regensburg
Multiple oncogenic mutations and clonal relationship in spatially distinct benign human epidermal tumors

Ilknur Senyürek, Tübingen
Extracellular matrix components in skin barrier function

Carina Hillgruber, Münster
Von Willebrand factor promotes cutaneous inflammation

Christoffer Gebhardt, Heidelberg
Endothelial cell-specific functions of RAGE signaling in inflammation and cancer

Florian Woelbing, Tübingen
Dissecting early and late phase mast cell activation pathways: Serum- and glucocorticoid-inducible kinase 1 is critical for early but dispensable for delayed type mast cell responses

Lena Hardkop, Lübeck
The dermato-endocrine regulator melatonin modifies the time- and dose-dependent UV-response in a human full skin model in vitro

Christian Hofmann, Erlangen
TCR-RNA-reprogrammed T cells are able to recognize HIV-epitopes

Angela Nagel, Marburg
The clinical activity of pemphigus vulgaris is directly linked to IgE autoantibodies reactive with desmoglein 3

Jennifer Landsberg, Bonn
Neonatal UV irradiation promotes multistage melanomagenesis in the Hgf-Cdk4R24C C57BL/6 mouse tumor model